Analystreport

Aquestive Therapeutics Inc (NASDAQ: AQST) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "sell" rating.

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations